Results of medium-term survival in patients undergoing cardiac transplantation: institutional experience

Fuente: Redalyc
Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: Ires Lopes Custódio
Format: Artículo científico
Sprache:en
Veröffentlicht: Sociedade Brasileira de Cirurgia Cardiovascular 2013
Schlagworte:
Online-Zugang:
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
_version_ 1876474269995630592
author Ires Lopes Custódio
author_facet Ires Lopes Custódio
contents Results of medium-term survival in patients undergoing cardiac transplantation: institutional experience Ires Lopes Custódio Francisca Elisângela Teixeira Lima Marcos Venícios de Oliveira Lopes Viviane Martins da Silva João David Santos Neto Maria do Perpétuo Socorro Martins Samya Coutinho de Oliveira Medicina Mortality Survival rate Heart transplantation Introduction: The heart transplant became a consecrated therapy for patients with terminal heart failure, increasingly improving the survival. Objective: To identify the medium-term results in patients undergoing cardiac transplantation. Methods: This is a descriptive, documentary and retrospective study, using a quantitative approach, developed in a Unit of Transplant and Heart Failure, of a tertiary level public hospital, located in Fortaleza, CE, Brazil. The data were obtained from a sample of 188 patients (154 men and 34 women), submitted to the heart transplant, in the period from October 1997 to March 2011. There were calculated survival rates based on Kaplan-Meier methods. Results: There were identified information about the patient’s gender (male 81.91%), medical diagnosis which determined the heart transplantation (idiopathic cardiomyopathies 23.98%, ischemic 23.4% and Chagasic 17.02%). The median age of patients was 48 years old (interquartile range = 17.25 years) and the median observation period was 877 days. During this period, 78 patients died, resulting in survival ratios of 72%, 59% and 47% after 1, 5 and 9 years of cardiac transplantation, respectively. Younger patients had longer survival (P=0.0418). Conclusion: The medium-term survival of patients undergoing cardiac transplantation is significant, especially for younger patients. 2013 artículo científico 0102-7638 https://www.redalyc.org/articulo.oa?id=398941891010 en http://www.redalyc.org/revista.oa?id=3989 Revista Brasileira de Cirurgia Cardiovascular/Brazilian Journal of Cardiovascular Surgery application/pdf Sociedade Brasileira de Cirurgia Cardiovascular Revista Brasileira de Cirurgia Cardiovascular/Brazilian Journal of Cardiovascular Surgery (Brasil) Num.4 Vol.28
format Artículo científico
id redalyc_398941891010
institution Redalyc
language en
publishDate 2013
publisher Sociedade Brasileira de Cirurgia Cardiovascular
spellingShingle Results of medium-term survival in patients undergoing cardiac transplantation: institutional experience
Ires Lopes Custódio
Medicina
Mortality
Survival rate
Heart transplantation
Results of medium-term survival in patients undergoing cardiac transplantation: institutional experience Ires Lopes Custódio Francisca Elisângela Teixeira Lima Marcos Venícios de Oliveira Lopes Viviane Martins da Silva João David Santos Neto Maria do Perpétuo Socorro Martins Samya Coutinho de Oliveira Medicina Mortality Survival rate Heart transplantation Introduction: The heart transplant became a consecrated therapy for patients with terminal heart failure, increasingly improving the survival. Objective: To identify the medium-term results in patients undergoing cardiac transplantation. Methods: This is a descriptive, documentary and retrospective study, using a quantitative approach, developed in a Unit of Transplant and Heart Failure, of a tertiary level public hospital, located in Fortaleza, CE, Brazil. The data were obtained from a sample of 188 patients (154 men and 34 women), submitted to the heart transplant, in the period from October 1997 to March 2011. There were calculated survival rates based on Kaplan-Meier methods. Results: There were identified information about the patient’s gender (male 81.91%), medical diagnosis which determined the heart transplantation (idiopathic cardiomyopathies 23.98%, ischemic 23.4% and Chagasic 17.02%). The median age of patients was 48 years old (interquartile range = 17.25 years) and the median observation period was 877 days. During this period, 78 patients died, resulting in survival ratios of 72%, 59% and 47% after 1, 5 and 9 years of cardiac transplantation, respectively. Younger patients had longer survival (P=0.0418). Conclusion: The medium-term survival of patients undergoing cardiac transplantation is significant, especially for younger patients. 2013 artículo científico 0102-7638 https://www.redalyc.org/articulo.oa?id=398941891010 en http://www.redalyc.org/revista.oa?id=3989 Revista Brasileira de Cirurgia Cardiovascular/Brazilian Journal of Cardiovascular Surgery application/pdf Sociedade Brasileira de Cirurgia Cardiovascular Revista Brasileira de Cirurgia Cardiovascular/Brazilian Journal of Cardiovascular Surgery (Brasil) Num.4 Vol.28
title Results of medium-term survival in patients undergoing cardiac transplantation: institutional experience
topic Medicina
Mortality
Survival rate
Heart transplantation
url https://www.redalyc.org/articulo.oa?id=398941891010